Top Buy
| Wertpapier ▼ | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Neurocrine Bioscience | 42 | 0 | 10 | 0 | 131,45 € | 149,47 € | 13,71 % |
| Nektar Therapeutics | 4 | 1 | 0 | 0 | 1,09 € | 2,40 € | 120,39 % |
| MorphoSys AG | 7 | 0 | 0 | 0 | 67,40 € | 65,00 € | -3,56 % |
| Merck KGaA | 5 | 2 | 2 | 1 | 167,55 € | 172,00 € | 2,66 % |
| Merck & Co. Inc. | 33 | 1 | 4 | 0 | 103,20 € | 125,72 € | 21,82 % |
| Medpace Holdings Inc | 16 | 0 | 4 | 0 | 350,90 € | 418,12 € | 19,16 % |
| MannKind Corp. | 8 | 0 | 0 | 0 | 4,73 € | 6,03 € | 27,32 % |
| Madrigal Pharmaceuticals inc. | 3 | 0 | 0 | 0 | 227,50 € | 315,00 € | 38,46 % |
| Lisata Therapeutics Inc. | 1 | 0 | 0 | 0 | 2,42 € | 4,00 € | 65,29 % |
| Lexicon Pharmaceuticals Inc. | 7 | 0 | 3 | 0 | 1,49 € | 9,17 € | 515,44 % |
| Krystal Biotech | 18 | 0 | 2 | 0 | 174,60 € | 184,02 € | 5,40 % |
| Knight Therapeutics | 1 | 0 | 0 | 0 | 3,76 € | 10,00 € | 165,96 % |
| Kezar Life Sciences | 7 | 0 | 2 | 0 | 0,54 € | 18,42 € | 3311,48 % |
| Kala Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | 5,31 € | 18,02 € | 239,77 % |
| Johnson & Johnson | 41 | 1 | 7 | 0 | 144,62 € | 196,23 € | 35,69 % |
| Jazz Pharmaceuticals plc | 29 | 0 | 5 | 0 | 101,60 € | 184,14 € | 81,24 % |
| Ipsen S.A. | 1 | 0 | 0 | 0 | 105,70 € | 109,00 € | 3,12 % |
| Iovance Biotherapeutics Inc. | 21 | 2 | 1 | 0 | 9,54 € | 26,24 € | 175,07 % |
| Ionis Pharmaceuticals Inc. | 28 | 6 | 8 | 1 | 42,13 € | 56,72 € | 34,63 % |
| Intra-Cellular Therapies Inc. | 30 | 0 | 3 | 0 | 69,00 € | 85,00 € | 23,19 % |
| Intellia Therapeutics Inc | 16 | 1 | 2 | 0 | 20,54 € | 60,12 € | 192,69 % |
| Insmed Inc. | 45 | 0 | 6 | 0 | 69,00 € | 77,15 € | 11,81 % |
| Innoviva Inc. | 6 | 0 | 1 | 0 | 16,50 € | 30,00 € | 81,82 % |
| Incyte Corp. | 13 | 2 | 2 | 0 | 56,38 € | 77,67 € | 37,76 % |
| Immutep LTD ADR | 1 | 0 | 0 | 0 | 2,06 € | 4,00 € | 94,17 % |